Biotricity Inc. (“Biotricity”) and B-Secur, a leader in biosensing technology, have joined forces to create one of the most advanced, device-neutral platforms for integrated heart monitoring.  By combining B-Secur’s HeartKey^® technology, a suite of FDA-cleared algorithms and analytics, with Biotricity’s medical and consumer diagnostic solutions, the new partnership will empower Integrated Delivery Networks, healthcare providers, health systems, and Independent Diagnostic Testing Facilities with enhanced capabilities for Ambulatory Cardiac Monitoring and ambulatory devices.